Marimed (MRMD) Dividends Paid - Common Growth (1y) (2018 - 2026)
Marimed (MRMD) Dividends Paid - Common Growth (1y) (2018 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Div. Paid (Common) Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 89.28 Bn | 87.42 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 35.97 Bn | 32.23 Bn | 1.97 Bn | - |
| 3 | Zoetis | 32.42 Bn | 30.48 Bn | 1.62 Bn | 0.00% |
| 4 | Takeda Pharmaceutical | 27.48 Bn | 23.42 Bn | 4.39 Bn | 0.40% |
| 5 | United Therapeutics | 22.89 Bn | 20.73 Bn | 648.10 Mn | - |
| 6 | RedHill Biopharma | 22.11 Bn | 22.11 Bn | - | - |
| 7 | Viatris | 20.44 Bn | 18.64 Bn | 1.16 Bn | -2.58% |
| 8 | Neurocrine Biosciences | 17.76 Bn | 16.44 Bn | 800.70 Mn | - |
| 9 | Elanco Animal Health | 12.62 Bn | 12.19 Bn | 785.00 Mn | - |
| 10 | Marimed | 25.72 Mn | 17.78 Mn | 15.28 Mn | -15.52% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -15.52% |
| Dec 31, 2025 | 15.79% |
| Sep 30, 2025 | -74.36% |
| Jun 30, 2025 | -38.46% |
| Mar 31, 2025 | 28.89% |
| Dec 31, 2024 | -36.67% |
| Sep 30, 2024 | -79.26% |
| Jun 30, 2024 | -93.09% |
| Mar 31, 2024 | 32.35% |
| Dec 31, 2023 | -98.31% |
| Sep 30, 2023 | 17.50% |
| Jun 30, 2023 | -43.37% |
| Mar 31, 2023 | -66.34% |
| Dec 31, 2022 | 690.03% |
| Sep 30, 2022 | -66.10% |
| Jun 30, 2022 | -17.00% |
| Mar 31, 2022 | 21.69% |
| Dec 31, 2021 | -478.03% |
| Sep 30, 2021 | 89.17% |
| Jun 30, 2021 | 51.41% |